ArticleNature communications2026
Molecular basis of collagen galactosylation by GLT25D1.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular basis of collagen galactosylation by GLT25D1.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
GLT25D1 O-galactosylates hydroxylysine residues in collagen and is essential for collagen maturation and function. Dysfunctions of GLT25D1 cause various tissue disorders. Despite its biological significance, the action mechanism of GLT25D1 remains enigmatic. Here we report the cryo-EM structures of human GLT25D1 and its ternary complex with UDP and hydroxylated acceptor substrates, revealing a bi-lobe architecture for the GLT25D1 monomer that organizes into dimeric and hexameric oligomers. The N-lobe of GLT25D1 contains a high-affinity UDP-galactose binding site, and the C-lobe is the catalytic domain of the enzyme. The structures together with biochemical analyses unravel the key recognition of the consensus "Hyl-Gly" motif from collagen acceptor substrates and associated catalytic mechanism. We further demonstrate that GLT25D1 mutations linked to cerebral small vessel disease and musculoskeletal defects adversely affect its function via distinct mechanisms. Our findings elucidate the molecular mechanism underlying collagen glycosylation and provide a molecular framework for understanding GLT25D1-related diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.